BridgeMD
New treatment option for Locally Advanced Bladder Carcinoma
Official title An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers
ClinicalTrials.gov ID: NCT06414317
What this study is testing
- What it's testing
- This clinical trial evaluates the impact of an education and navigation support tool (ENST) on patient and caregiver participation in care coordination for bladder cancer that has spread to nearby tissue or lymph nodes (locally advanced), to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Patients with advanced bladder cancer tend to be older, have multiple medical conditions and often have poor access to health care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- PATIENTS: Age ≥ 18 years
- PATIENTS: Metastatic or locally advanced, unresectable bladder cancer
- PATIENTS: Receiving or planning to receive systemic therapy for bladder cancer at Roswell Park Comprehensive Cancer Center (RPCCC)
- PATIENTS: people can be enrolled any time from initial diagnosis of advanced disease to within 8 weeks after initiation of first-line systemic...
- PATIENTS: Able to speak, understand, read, and write English
You likely can't join if
- PATIENTS: Not receiving any form of systemic therapy for bladder cancer due to Eastern Cooperative Oncology Group (ECOG) performance status (PS) \>...
- PATIENTS: Predominantly small cell histology
- PATIENTS: Adults with impaired decision-making capacity, assessed by the study team to be unable to participate in ENST-based education and surveys
- PATIENTS: Pregnant women
- CAREGIVERS: Cognitively impaired adults/adults with impaired decision-making capacity
- CAREGIVERS: Individuals who are not yet adults (infants, children, teenagers)
See the full eligibility criteria
- PATIENTS: Age ≥ 18 years
- PATIENTS: Metastatic or locally advanced, unresectable bladder cancer
- PATIENTS: Receiving or planning to receive systemic therapy for bladder cancer at Roswell Park Comprehensive Cancer Center (RPCCC)
- PATIENTS: people can be enrolled any time from initial diagnosis of advanced disease to within 8 weeks after initiation of first-line systemic therapy for advanced bladder cancer
- PATIENTS: Able to speak, understand, read, and write English
- CAREGIVERS: Age ≥ 18 years
- CAREGIVERS: Only caregivers of enrolled patients will be included in the study
- CAREGIVERS: Should be able to speak, understand, read, and write English
- CAREGIVERS: Caregivers will be enrolled in the study during the same time window as for patient enrollment (from initial visit to within 8 weeks of patients starting frontline therapy)
- PATIENTS: Not receiving any form of systemic therapy for bladder cancer due to Eastern Cooperative Oncology Group (ECOG) performance status (PS) \> 3, co-morbidities, or inadequate organ function
- PATIENTS: Predominantly small cell histology
- PATIENTS: Adults with impaired decision-making capacity, assessed by the study team to be unable to participate in ENST-based education and surveys
- PATIENTS: Pregnant women
- CAREGIVERS: Cognitively impaired adults/adults with impaired decision-making capacity
- CAREGIVERS: Individuals who are not yet adults (infants, children, teenagers)
The study team makes the final eligibility decision.
Where it's taking place
- Buffalo, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Buffalo, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.